Skip to main content

Table 5 The average annual costs of disease conditions in Turkey

From: Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey

Disease states Original costs (TL/year)
Year 2009 (TL) 2014a (TL)
Compensated cirrhosis 6778 7857
Decompensated cirrhosis 7573 8780
Hepatocellular carcinoma 31,044 35,989
  1. a2014 costs were calculated by using 3 % reduction ratio according to 2009
Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us